Now Accepting Public Comments through June 8, 2026 on the Draft 2027 CMS QRDA III Implementation Guide, Schematron, and Sample File for Eligible Clinicians
Constrained to 'Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)' SNOMEDCT code
Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.
Timing: